These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Two-stage transvesical adenomectomy in adenomatous hypertrophy of the prostate]. BLIZNIUK VM Urol Mosc; 1956; 21(3):18-21. PubMed ID: 13401628 [No Abstract] [Full Text] [Related]
7. [Complex therapy of irritative voiding disorders after transurethral resection of the prostate and adenomectomy]. Markov AV; Luk'ianov IV; Loran OB Urologiia; 2007; (4):41-4. PubMed ID: 17915448 [TBL] [Abstract][Full Text] [Related]
8. [Technic of prostatectomy (adenomectomy)]. DE LA PENA E Bol Cult Inf Cons Gen Col Med Esp; 1956 Jun; 19(101):7-9. PubMed ID: 13436543 [No Abstract] [Full Text] [Related]
9. Holmium laser treatment of benign prostatic hyperplasia: an update. Matlaga BR; Miller NL; Lingeman JE Curr Opin Urol; 2007 Jan; 17(1):27-31. PubMed ID: 17143108 [TBL] [Abstract][Full Text] [Related]
10. Dilemmas in the treatment of urothelial cancers of the prostate. Walsh DL; Chang SS Urol Oncol; 2009; 27(4):352-7. PubMed ID: 18439852 [TBL] [Abstract][Full Text] [Related]
12. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate. Zhigang Z; Wenlu S Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024 [TBL] [Abstract][Full Text] [Related]
13. Concomitant pathology in the prostate in cystoprostatectomy specimens: a prospective study and review. Saad M; Abdel-Rahim M; Abol-Enein H; Ghoneim MA BJU Int; 2008 Dec; 102(11):1544-50. PubMed ID: 18565169 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of prostate specific antigen (PSA) in benign and malignant tumors of the prostate. Dema A; Tudose N Rom J Morphol Embryol; 1998; 44(1-4):93-100. PubMed ID: 15678849 [TBL] [Abstract][Full Text] [Related]